ECM
CHE icon

Everence Capital Management’s Chemed CHE Stock Holding History

Everence Capital Management’s Portfolio CHE Stock Details CHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$321K Buy
+689
New +$290K 0.02% 603
2017
Q2 		– Sell
-1,470
Closed -$269K – 375
2017
Q1 		$269K Buy
+1,470
New +$256K 0.07% 291

Other funds holding CHE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Everence Capital Management's CHE Position: Q2 2026 in Review

Everence Capital Management opened a new position in Chemed (CHE) in Q2 2026: 689 shares worth $321K. The stake represents 0.02% of the portfolio and ranks #603 among its holdings. This is a return to the name: Everence Capital Management previously reported a position in CHE as recently as Q1 2017.

Everence Capital Management first reported a position in CHE in Q1 2017 and has held it in 2 quarters since. 532 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • Everence Capital Management held 689 shares of Chemed worth $321K as of Q2 2026.
  • Chemed was a new Everence Capital Management position in Q2 2026.
  • Chemed made up 0.02% of Everence Capital Management's portfolio in Q2 2026, its #603 holding.
  • Everence Capital Management first reported a position in Chemed in Q1 2017 and has held it in 2 quarters since.
  • 532 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on Everence Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.